InPlay: Albany Molecular misses by $0.02, guides Q4 below consensus
Does this bother you? I think it is good that they are not another Enron hitting things on the mark. I think this is still a great holding. It is growing well and a good value.
52-Week Change (relative to S&P500): -22.31% yep, just lovely